Business Description

Rapid Therapeutic Science Laboratories Inc logo
Rapid Therapeutic Science Laboratories Inc
NAICS : 334510 SIC : 3842
ISIN : US4357361033
Description
Rapid Therapeutic Science Laboratories Inc is a biotech company specializing in natural-based relief through aerosol delivery of cannabinoids to the systemic bloodstream through the pulmonary route of administration. The company manufactures its own branded metered dose inhalers (MDI) under the nhaler name using proprietary blends of pure cannabinoids such as cannabidiol (CBD) and cannabigerol (CBG). In addition, the company manufactures other aerosol devices for the delivery of cannabinoids other than MDI such as sublingual sprays.

Financial Strength

Name Current Vs Industry Vs History
Equity-to-Asset -1.32
Debt-to-Equity -1.38
Debt-to-EBITDA 5.63
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EPS without NRI Growth Rate 61.8
3-Year FCF Growth Rate 59
3-Year Book Growth Rate 81.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 60.79
9-Day RSI 63.4
14-Day RSI 64.42
6-1 Month Momentum % -29.17
12-1 Month Momentum % -97.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.07
Quick Ratio 0.03

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -444.3
Shareholder Yield % -3176.14

Profitability Rank

Name Current Vs Industry Vs History
ROE % Neg. Equity
ROA % 2.66
ROIC % -9.54
ROC (Joel Greenblatt) % 36.67

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio 0.5
EV-to-EBIT 5.91
EV-to-EBITDA 5.7
EV-to-FCF -15.31
Earnings Yield (Greenblatt) % 16.92
FCF Yield % -568.18

Financials (Next Earnings Date:2024-05-10 Est.)

RTSL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:RTSL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Rapid Therapeutic Science Laboratories Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) 0.01
Beta 1.82
Volatility % 101.87
14-Day RSI 64.42
14-Day ATR ($) 0.000253
20-Day SMA ($) 0.004465
12-1 Month Momentum % -97.88
52-Week Range ($) 0.0005 - 0.16
Shares Outstanding (Mil) 8.83

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rapid Therapeutic Science Laboratories Inc Filings

Filing Date Document Date Form
No Filing Data

Rapid Therapeutic Science Laboratories Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Rapid Therapeutic Science Laboratories Inc Frequently Asked Questions

What is Rapid Therapeutic Science Laboratories Inc(RTSL)'s stock price today?
The current price of RTSL is $0.01. The 52 week high of RTSL is $0.16 and 52 week low is $0.00.
When is next earnings date of Rapid Therapeutic Science Laboratories Inc(RTSL)?
The next earnings date of Rapid Therapeutic Science Laboratories Inc(RTSL) is 2024-05-10 Est..
Does Rapid Therapeutic Science Laboratories Inc(RTSL) pay dividends? If so, how much?
Rapid Therapeutic Science Laboratories Inc(RTSL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1